gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Zinc finger protein 77

Sponsored links
Top mentioned proteins: HAD, AGE, CAN, iMpact, NODAL
Papers using pT1 antibodies
High-resolution profiling of histone methylations in the human genome
Kiltie Anne E. et al., In Carcinogenesis, 2006
... , 10 pT1 at least G2/G3, six pT2 at least G3 and one pTxG3) was extracted using a QIAamp DNA Micro kit (Qiagen, Crawley, UK), and DNA ...
Papers on pT1
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
Harpole et al., Durham, United States. In J Clin Oncol, Feb 2016
RESULTS: Of 1,574 patients who had pT1-2N0M0 SCLC during the study period, 954 patients (61%) underwent complete R0 resection with a 5-year survival of 47%.
Transanal endoscopic microsurgery for giant circumferential rectal adenomas.
Morino et al., Torino, Italy. In Colorectal Dis, Feb 2016
Surgical histology showed a pT3 cancer in one patient who refused further surgery, a pT2 cancer in two who subsequently underwent abdominoperineal resection, a pT1 cancer in four and a ypT0 in one patient.
[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
Villegas et al., Cali, Colombia. In Enferm Infecc Microbiol Clin, Feb 2016
CTX-M-15-producing E.coli showed 10 different pulsotypes, 65% were PT1 or PT4, and corresponded to ST131.
Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.
Tanabe et al., Tokyo, Japan. In Int Urol Nephrol, Feb 2016
Fourteen patients underwent immediate total cystectomy after the diagnosis of muscle-invasive bladder cancer or high-grade pT1 tumors.
Mayo Adhesive Probability (MAP) Score is Associated with Localized Renal Cell Carcinoma Progression-Free Survival.
Parker et al., Jacksonville, United States. In Urology, Jan 2016
Of interest, the association with MAP and PFS remains for pT1 RCC patients (n=287, HR= 3.46 [1.06-11.24],
Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy.
Schmidberger et al., Mainz, Germany. In Adv Exp Med Biol, Dec 2015
CA IX was also present more frequently in pathological tumor stage T1 (pT1) tumors (p = 0.048).
The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancer.
Ma et al., Rochester, United States. In Chin Clin Oncol, Sep 2015
This strategy incorporates the findings that: higher expression of the proliferation marker, Ki67, after 2 weeks of neoadjuvant endocrine therapy (ET), is associated with poor recurrence-free survival, and that patients with surgical findings of pT1/2, pN0 disease, Ki67 ≤2.7% and ER Allred score of 3-8 after neoadjuvant ET have extremely low recurrence rates.
Papillary in situ and intramucosal adenocarcinoma of the lower third of common bile duct. A report and review of the literature.
Mendoza-Barrera et al., Mexico. In Ann Hepatol, May 2015
The pathologic Tumor-Node-Metastasis (TNM) stage was pT1, pN0, pM0, R0.
Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis.
Wang et al., Shenyang, China. In Dis Markers, 2014
Results showed that there were significant differences in the incidence of high CA 19-9 levels between stages III/IV and I/II groups (OR = 3.36; 95% CI = 2.34-4.84), the pT3/T4 and pT1/T2 groups (OR = 2.40; 95% CI = 1.60-3.59),
Primary neuroendocrine tumor (carcinoid tumor) of the testis: a case report with review of literature.
Heimann et al., United States. In Am J Case Rep, 2014
The tumor was staged as pT1 N0 M0 S2.
Penile cancer: about ten cases at the University Hospital of Rabat, review of the literature.
Attaya et al., Rabat, Morocco. In Pan Afr Med J, 2014
All tumors had a distal seat (gland- Furrow balanopreputial), 8 were localized and non-invasive (PT1 - PT2) and 2 had infiltrated the urethra (PT3).
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
START Trialists' Group et al., United Kingdom. In Lancet Oncol, 2013
METHODS: From 1999 to 2002, women with completely excised invasive breast cancer (pT1-3a, pN0-1, M0) were enrolled from 35 UK radiotherapy centres.
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial et al., Villejuif, France. In N Engl J Med, 2012
Inclusion criteria were an age of 18 years or older; total thyroidectomy for differentiated thyroid carcinoma; tumor-node-metastasis (TNM) stage, ascertained on pathological examination (p) of a surgical specimen, of pT1 (with tumor diameter ≤1 cm) and N1 or Nx, pT1 (with tumor diameter >1 to 2 cm) and any N stage, or pT2N0; absence of distant metastasis; and no iodine contamination.
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Cote et al., Chicago, United States. In J Clin Oncol, 2011
PATIENTS AND METHODS: Patients with pT1/T2N0M0 disease whose tumors demonstrated ≥ 10% nuclear reactivity on centrally performed immunohistochemistry for p53 were offered random assignment to three cycles of adjuvant MVAC versus observation; p53-negative patients were observed.
share on facebooktweetadd +1mail to friends